FDA
-
-
-
-
-
-
-
Beyond Air Schedules Conference Call to Discuss Financial Results for the Quarter Ended June 30, 2026
-
-
-
-
-
-
-
Beyond Cancer presents Phase 1 UNO trial survival data at AACR 2026
-
-
-
-
-
-
-
Beyond Cancer reports early clinical activity in Phase 1 cancer trial
-
-
-
-
-
-
-
Beyond Air® Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
XTL Biopharmaceuticals acquires 85% stake in NeuroNOS for autism therapeutics
-
-
-
-
-
-
-
Beyond Air® Signs New International LungFit PH® Distribution Agreements, Most Notably in Germany and Brazil
-
-
-
-
-
-
-
Beyond Air to Participate in the ROTH 4th Annual Healthcare Opportunities Conference
-
334,274 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


